Montesclaros, Jennelyn T.

HRN: 13-51-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2025
CEFUROXIME 1.5GM (VIAL)
09/02/2025
09/06/2025
IVT
1.5
OD
S/P Repeat LTCS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines